- The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis
Luyao Chen et al, 2015, Medicine CrossRef - Effect of smoking, hypertension and lifestyle factors on kidney cancer — perspectives for prevention and screening programmes
Riccardo Campi et al, 2023, Nature Reviews Urology CrossRef - Influence of statin use on prognosis of patients with renal cell cancer: a meta-analysis
Wenli Liang et al, 2023, Frontiers in Oncology CrossRef - Statin use and kidney cancer survival outcomes: A systematic review and meta-analysis
Madhur Nayan et al, 2017, Cancer Treatment Reviews CrossRef - The Prognostic Effect of Statin Use on Urologic Cancers
You Luo et al, 2015, Medicine CrossRef - Statins: Do They Have a Potential Role in Cancer Prevention and Modifying Cancer-Related Outcomes?
Stefanos Bonovas, 2014, Drugs CrossRef - Effects of statins on cancer mortality and progression: A systematic review and meta‐analysis of 95 cohorts including 1,111,407 individuals
Zubing Mei et al, 2017, International Journal of Cancer CrossRef - Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent Mechanism
Jordan M. Thompson et al, 2018, Molecular Cancer Therapeutics CrossRef - Statin use and kidney cancer outcomes: A propensity score analysis
Madhur Nayan et al, 2016, Urologic Oncology: Seminars and Original Investigations CrossRef - The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy
Boyd R. Viers et al, 2015, Urologic Oncology: Seminars and Original Investigations CrossRef - Relationship Between the Use of Statins and Patient Survival in Colorectal Cancer: A Systematic Review and Meta-Analysis
Heping Cai et al, 2015, PLOS ONE CrossRef - Statin Use and Serum Lipid Levels Are Associated With Survival Outcomes After Surgery for Renal Cell Carcinoma
Ahmed Q. Haddad et al, 2015, Urology CrossRef - Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
Yoichi Morofuji et al, 2022, Pharmaceuticals CrossRef